Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perrin E Romine

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
BMC Cancer|January 16, 2019
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcomePerrin E Romine, Renato G Martins, Keith D Eaton, et al.
Breast Cancer Research : BCR|August 24, 2021
<sup>18</sup>F-fluorodeoxyglucose (FDG) PET or <sup>18</sup>F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity studyPerrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
BMC Cancer|January 16, 2019
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcomePerrin E Romine, Renato G Martins, Keith D Eaton, et al.
Breast Cancer Research : BCR|August 24, 2021
<sup>18</sup>F-fluorodeoxyglucose (FDG) PET or <sup>18</sup>F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity studyPerrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.
Pageof 2